Tag: Biotech

Gingko Bioworks, valued at $15B, begins trading today: Here’s how their business works

Gingko Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. Gingko’s market debut is one of the largest in biotech history. It’s expected to raise about $1.6 billion for the company. It’s also one of the biggest SPAC deals…

Read More

Rani Therapeutics’ $73M IPO will fund upcoming clinical trials

Rani Therapeutics, a San Jose-based company developing a pill to replace medical injections, went public on Friday.  According to S-1 filings, shares were estimated to price between $14 and $16 last week. On Friday, shares debuted slightly lower, around $11. Rani raised about $73 million in its debut. Rani’s debut…

Read More

Planted raises another $21M to expand its growing plant-based meat empire (and add schnitzel)

Swiss alternative protein company Planted has raised its second round of the year, a CHF 19M (about $21M at present) “pre-B” fundraise that will help it continue its growth and debut new products. A U.S. launch is in the cards eventually but for now Planted’s exclusively European customers will be…

Read More

Pivot Bio rakes in $430M round D as modified microbes prove their worth in agriculture

Pivot Bio makes fertilizer — but not directly. Its modified microorganisms are added to soil and they produce nitrogen that would otherwise have to be trucked in and dumped there. This biotech-powered approach can save farmers money and time and ultimately may be easier on the environment — a huge…

Read More

In an increasingly hot biotech market, protecting IP is key

John Flavin Contributor More posts by this contributor 2021 should be a banner year for biotech startups that make smart choices early Kevin O’Connor Contributor Kevin A. O’Connor, Ph.D., is a partner in the Intellectual Property practice group at Neal Gerber Eisenberg. After a record year for biotech investment in…

Read More

Nigeria’s MDaaS launches new healthtech product on the back of $2.3M seed extension

It is no secret that healthcare in Nigeria and most parts of Africa is not easily available and a lot of work needs to be done in that regard. However, there are instances where accessibility is taken for granted. Take for instance Nigeria where a majority of the population with…

Read More